Financial insights of MDT

MyFinsight

For the quarter ending 2025-10-24, MDT made $8,961M in revenue. $1,374M in net income. Net profit margin of 15.33%.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement	2025-10-24	2025-07-25	2025-01-24	2024-10-25
Net sales	8,961	8,578	8,292	8,403
Cost of products sold, excluding amortization of intangible assets	3,061	3,001	2,779	2,946
Research and development expense	754	726	675	697
Selling, general, and administrative expense	2,965	2,806	2,717	2,757
Amortization of intangible assets	463	459	416	413
Restructuring charges, net	10	45	43	30
Certain litigation charges, net	0	27	22	0
Other operating expense (income), net	-22	-70	5	34
Operating profit	1,686	1,445	1,646	1,595
Other non-operating income, net	92	33	72	173
Interest expense, net	181	176	179	209
Income before income taxes	1,597	1,302	1,540	1,559
Income tax provision	215	255	237	281
Net income	1,381	1,047	1,303	1,278
Net income attributable to noncontrolling interests	7	7	9	9
Net income attributable to medtronic	1,374	1,040	1,294	1,270

Basic earnings per share (in dollars per share)	1.07	0.81	1.01	0.99
Basic weighted average shares outstanding (in shares)	1,282,000,000	1,281,600,000	1,282,400,000	1,282,400,000
Diluted earnings per share (in dollars per share)	1.07	0.81	1.01	0.99
Diluted weighted average shares outstanding (in shares)	1,288,000,000	1,287,100,000	1,286,200,000	1,286,900,000